Core Viewpoint - The company, Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd., has announced its profit distribution plan for the first three quarters of 2025, which includes a cash dividend of RMB 0.22 per 10 shares, totaling RMB 4,518,870.40, approved by the shareholders' meeting on November 13, 2025 [1][2]. Summary by Sections Shareholders' Meeting Approval - The profit distribution plan was approved at the third extraordinary shareholders' meeting held on November 13, 2025, based on a total share capital of 205,403,200 shares [1][2]. - The distribution will not include stock dividends or capital reserve transfers, with any undistributed profits carried forward to future periods [1]. Implementation of the Distribution Plan - The cash dividend of RMB 0.22 per 10 shares (before tax) will be distributed to all shareholders, with specific tax implications for different types of shareholders [2]. - The total cash dividend amounts to RMB 4,518,870.40, and adjustments will be made if the total shares change before the distribution [1][2]. Key Dates - The record date for the distribution is set for December 12, 2025, and the ex-dividend date is December 15, 2025 [3]. Distribution Method - Cash dividends will be directly credited to shareholders' accounts through their custodial securities companies on the ex-dividend date [4]. - The company will bear all legal responsibilities if there are any issues with the distribution due to changes in shareholders' accounts during the application period [4]. Adjustments Related to the Distribution - The minimum selling price for shares held by shareholders who committed to not selling within two years post-lockup will be adjusted to RMB 12.1680 per share following the cash dividend distribution [4]. - The company will also adjust the grant and exercise prices for restricted stock options in accordance with its incentive plan after the distribution is completed [4].
湖南达嘉维康医药产业股份有限公司2025年前三季度权益分派实施公告